This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Poised to Pop on Bullish Earnings

Forest Laboratories

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Another potential earnings short-squeeze trade is biotechnology and drugs player Forest Laboratories (FRX), which is set to release its numbers on Tuesday before the market open. This company develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician's prescription. Wall Street analysts, on average, expect Forest Laboratories to report revenue of $813.30 million on earnings of 24 cents per share.

This company is looking to top Wall Street estimates for the third quarter in a row this week. During the last quarter, Forest Laboratories beat Wall Street estimates after reporting net income of 78 cents per share vs. estimates of 71 cents per share. During the prior quarter, the company reported a profit of $1.04 a share.

The current short interest as a percentage of the float for Forest Laboratories is notable at 6.3%. That means that out of the 236.46 million shares in the tradable float, 16.6 million shares are sold short by the bears. If Forest Laboratories can deliver the numbers that the bulls are looking for, then this stock could see a tradable shorts-squeeze develop post-earnings.

From a technical perspective, FRX is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock has uptrending for the last six months, with shares trending higher from around $31 to a recent high of $36.44 a share. During that uptrend, shares of FRX have mostly made higher lows and higher highs, which is bullish technical price action. That move has now pushed FRX within range of triggering a near-term breakout trade post-earnings.

If you're bullish on FRX, then I would wait until after it reports numbers and look for long-biased trades if this stock takes out some near-term overhead resistance at $36.44 a share high volume. Look for volume on that move that hits near or above its three-month average action of 1.9 million shares. If we get that move, then FRX could easily hit $39 to $40 a share post-earnings if the bulls gain full control of this stock.

I would simply avoid FRX or look for short-biased trades if after earnings this stock fails to trigger that breakout and then takes out some near-term support at $34.86 and its 50-day moving average of $34.43 a share with high volume. If we get that move, then FRX will setup to re-test its next significant support levels at $33.04 to its 200-day moving average at $32.44 a share post-earnings.
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
FRX $99.00 -0.77%
EGHT $11.80 0.00%
PNFP $49.54 0.00%
URI $65.77 0.00%
UFPI $82.78 0.00%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs